NCT06114953 - Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients | Biotech Hunter

Enrollment

152

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

March 1, 2025

Conditions

Kidney Transplant Immunosuppression

Interventions

DRUG

Mizoribine

Mizoribine+glucocorticoid+tacrolimus after kidney transplantation

DRUG

Mycophenolate Mofetil

Mycophenolate Mofetil+glucocorticoid+tacrolimus after kidney transplantation

Trial Locations (6)

RECRUITING

The Second Affiliated Hospital of Guangxi Medical University, Nanning

RECRUITING

Affiliated Hospital of Guizhou Medical University, Guiyang

NOT_YET_RECRUITING

First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

Beijing Friendship Hospital, Capital Medical University, Beijing

RECRUITING

West China Hospital, Sichuan University, Chengdu